CIK: 0001940272
申报总市值
US$17.0亿
申报季度: 2026-03-31 · 持股只数: 311
ADAR1 Capital Management, LLC在最新一期 13F 报告中披露了 311 项持股，申报期为 2026-03-31，总持股市值约为 US$17.0亿，季度换手率为 55.5%。
ADAR1 Capital Management, LLC 目前披露的持仓，Herfindahl 集中度指数为 0.025——换算下来相当于约 39 个等权重仓位，明显低于其实际披露的 311 只持仓。这一差距显示该机构的策略偏向集中在少数高信心仓位，而非广泛分散。
整体仓位大小差异较大（变异系数为 2.58），除少数重仓仓位外，还有许多规模较小的持仓。
最新申报季度中，并未观察到明显偏向加仓既有大仓位或大举建立新仓位的倾向。
目前行业板块分类约覆盖此投资组合披露价值的 2%；其余部分（例如未匹配板块的标的、期权或其他证券类型）尚未纳入板块分类范围。
减仓 ABVX
+9.2% -US$1752.5万
加仓 DNLI
+3490.9% US$3507.2万
加仓 430
+105.8% US$3688.6万
加仓 CRNX
+268.3% US$2697.9万
加仓 INSP
+2601.3% US$1951.7万
减仓 ABUS
-42.1% -US$1194.7万
仅显示前 200 大持股（共 311 只）
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABVX | Abivax Sa-adr | 股票-其他 | 9.43% | -3.62% | +9.16% | |
| 2 | PTGX | Protagonist Therapeutics INC | 股票-其他 | 6.17% | -0.56% | -5.25% | |
| 3 | ROIV | Roivant Sciences Ltd. | 股票-医疗保健 | 5.36% | -0.10% | -4.17% | |
| 4 | IMVT | Immunovant INC | 股票-其他 | 3.92% | — | +7.98% | |
| 5 | 430 | Terns Pharmaceuticals INC | 股票-其他 | 3.46% | +1.85% | +105.81% | |
| 6 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-大型股与成长 | 2.91% | +0.17% | +38.87% | |
| 7 | CYTK | Cytokinetics INC | 股票-医疗保健 | 2.45% | -0.07% | +17.10% | |
| 8 | CRNX | Crinetics Pharmaceuticals In | 股票-其他 | 2.44% | +1.38% | +268.28% | |
| 9 | BOXX | Alpha Architect 1-3 Mnth Box | ETF-其他 | 2.31% | — | — | |
| 10 | DNLI | Denali Therapeutics INC | 股票-其他 | 2.12% | +2.06% | +3490.94% | |
| 11 | BEAM | Beam Therapeutics INC | 股票-其他 | 2.03% | +2.03% | NEW | |
| 12 | ZLAB | Zai Lab Ltd-adr | 股票-其他 | 1.58% | -0.03% | +14.35% | |
| 13 | SEPN | Septerna INC | 股票-其他 | 1.54% | -0.83% | -5.86% | |
| 14 | VIR | Vir Biotechnology INC | 股票-其他 | 1.45% | +1.45% | NEW | |
| 15 | DBVT | Dbv Technologies Sa-spon Adr | 股票-其他 | 1.25% | +1.25% | NEW | |
| 16 | AVR | Anteris Technologies Global | 股票-其他 | 1.24% | +0.79% | +205.88% | |
| 17 | INSP | Inspire Medical Systems INC | 股票-医疗保健 | 1.23% | +1.13% | +2601.31% | |
| 18 | SRRK | Scholar Rock Holding CORP | 股票-其他 | 1.18% | +0.95% | +485.25% | |
| 19 | RYTM | Rhythm Pharmaceuticals INC | 股票-其他 | 1.08% | +0.68% | +311.79% | |
| 20 | SYRE | Spyre Therapeutics INC | 股票-其他 | 1.00% | +0.92% | +893.58% | |
| 21 | CTMX | Cytomx Therapeutics INC | 股票-其他 | 0.94% | — | -20.37% | |
| 22 | PRTA | Prothena Corporation plc | 股票-其他 | 0.90% | — | +8.48% | |
| 23 | SNY | Sanofi-adr | 股票-医疗保健 | 0.90% | +0.67% | +399.32% | |
| 24 | PCVX | Vaxcyte INC | 股票-其他 | 0.89% | — | -17.90% | |
| 25 | MNPR | Monopar Therapeutics INC | 股票-其他 | 0.85% | — | +12.98% | |
| 26 | ABUS | Arbutus Biopharma CORP | 股票-其他 | 0.83% | -1.08% | -42.14% | |
| 27 | AMLX | Amylyx Pharmaceuticals INC | 股票-其他 | 0.82% | — | +12.38% | |
| 28 | CLDX | Celldex Therapeutics INC | 股票-其他 | 0.80% | — | -33.85% | |
| 29 | TSHA | Taysha Gene Therapies INC | 股票-其他 | 0.78% | — | +19.38% | |
| 30 | XENE | Xenon Pharmaceuticals INC | 股票-其他 | 0.78% | — | +12.22% | |
| 31 | STRO | Sutro Biopharma INC | 股票-其他 | 0.77% | +0.71% | +681.85% | |
| 32 | RVMD | Revolution Medicines INC | 股票-医疗保健 | 0.77% | — | -7.71% | |
| 33 | ELVN | Enliven Therapeutics INC | 股票-其他 | 0.76% | +0.73% | +998.47% | |
| 34 | REPL | Replimune Group INC | 股票-其他 | 0.76% | — | +32.90% | |
| 35 | CGON | Cg Oncology INC | 股票-其他 | 0.74% | — | -28.06% | |
| 36 | BIL | Ss Spdr Bb 1-3m T-bill ETF | ETF-政府公债 | 0.73% | — | — | |
| 37 | ✓ | Establishment Labs Hldgs INC | 股票-其他 | 0.71% | — | +24.53% | |
| 38 | IVA | Inventiva SA - Adr | 股票-其他 | 0.71% | — | -19.76% | |
| 39 | IONS | Ionis Pharmaceuticals INC | 股票-医疗保健 | 0.71% | — | +8.98% | |
| 40 | NKTR | Nektar Therapeutics | 股票-其他 | 0.68% | +0.46% | +123.86% | |
| 41 | IKT | Inhibikase Therapeutics INC | 股票-其他 | 0.65% | -0.56% | -18.07% | |
| 42 | SPRY | Ars Pharmaceuticals INC | 股票-其他 | 0.64% | +0.32% | +268.41% | |
| 43 | ✓ | Helix Acquisition CORP Iii | 股票-其他 | 0.61% | +0.61% | NEW | |
| 44 | OVID | Ovid Therapeutics INC | 股票-其他 | 0.59% | — | +6.05% | |
| 45 | OKUR | Onkure Therapeutics Inc-a | 股票-其他 | 0.59% | +0.37% | +140.09% | |
| 46 | REGN | Regeneron Pharmaceuticals | 股票-医疗保健 | 0.55% | — | +0.85% | |
| 47 | MLTX | Moonlake Immunotherapeutics | 股票-其他 | 0.52% | +0.52% | NEW | |
| 48 | LXEO | Lexeo Therapeutics INC | 股票-其他 | 0.50% | -0.52% | +5.33% | |
| 49 | IRD | Opus Genetics INC | 股票-其他 | 0.50% | +0.49% | +4522.51% | |
| 50 | TEVA | Teva Pharmaceutical-sp Adr | 股票-医疗保健 | 0.48% | — | +13.74% |
Q3 2026表现
+21.1%
近4个季度表现
+26.3%
基于可获取价格的持仓（占申报价值的73%）计算
| 季度 | 持股只数 | 总市值 | 稳定性 | 主要持股 |
|---|---|---|---|---|
| 2026-03-31 | 311 | US$17.0亿 | 55 | |
| 2025-12-31 | 270 | US$13.6亿 | 68 | |
| 2025-09-30 | 220 | US$10.6亿 | 92 | |
| 2025-06-30 | 210 | US$6.5亿 | 0 | |
| 2025-03-31 | 202 | US$5.4亿 | 0 | |
| 2024-12-31 | 214 | US$5.0亿 | 0 | |
| 2024-09-30 | 278 | US$6.1亿 | 0 | |
| 2024-06-30 | 266 | US$5.3亿 | 0 | |
| 2024-03-31 | 261 | US$4.4亿 | 0 | |
| 2023-12-31 | 170 | US$2.8亿 | 0 |
ADAR1 Capital Management, LLC 在 2026-03-31 最显著的持仓异动： 清仓: Avidity Biosciences INC (RNAGBP); 新建仓: Beam Therapeutics INC (BEAM); 新建仓: Vir Biotechnology INC (VIR); 新建仓: Dbv Technologies Sa-spon Adr (DBVT); 清仓: Rapt Therapeutics INC (RAPT).
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | DNLI | Denali Therapeutics INC | +2.1% | +3490.94% | 加仓 |
| 2 | 430 | Terns Pharmaceuticals INC | +1.9% | +105.81% | 加仓 |
| 3 | CRNX | Crinetics Pharmaceuticals In | +1.4% | +268.28% | 加仓 |
| 4 | INSP | Inspire Medical Systems INC | +1.1% | +2601.31% | 加仓 |
| 5 | SRRK | Scholar Rock Holding CORP | +1% | +485.25% | 加仓 |
| 6 | SYRE | Spyre Therapeutics INC | +0.9% | +893.58% | 加仓 |
| 7 | AVR | Anteris Technologies Global | +0.8% | +205.88% | 加仓 |
| 8 | ELVN | Enliven Therapeutics INC | +0.7% | +998.47% | 加仓 |
| 9 | STRO | Sutro Biopharma INC | +0.7% | +681.85% | 加仓 |
| 10 | RYTM | Rhythm Pharmaceuticals INC | +0.7% | +311.79% | 加仓 |
| 11 | SNY | Sanofi-adr | +0.7% | +399.32% | 加仓 |
| 12 | IRD | Opus Genetics INC | +0.5% | +4522.51% | 加仓 |
| 13 | NKTR | Nektar Therapeutics | +0.5% | +123.86% | 加仓 |
| 14 | OKUR | Onkure Therapeutics Inc-a | +0.4% | +140.09% | 加仓 |
| 15 | VKTX | Viking Therapeutics INC | +0.4% | +759.50% | 加仓 |
| 16 | SPRY | Ars Pharmaceuticals INC | +0.3% | +268.41% | 加仓 |
| 17 | SRPT | Sarepta Therapeutics INC | +0.3% | +807.84% | 加仓 |
| 18 | SPY | Ss Spdr S&p 500 ETF Trust-us | +0.2% | +38.87% | 加仓 |
| 19 | ZLAB | Zai Lab Ltd-adr | 0% | +14.35% | 加仓 |
| 20 | CYTK | Cytokinetics INC | -0.1% | +17.10% | 加仓 |
| 21 | ROIV | Roivant Sciences Ltd. | -0.1% | -4.17% | 减仓 |
| 22 | IVVD | Invivyd INC | -0.4% | -1.97% | 减仓 |
| 23 | MAZE | Maze Therapeutics INC | -0.5% | -72.10% | 减仓 |
| 24 | ✓ | Crescent Biopharma INC. | -0.5% | -91.70% | 减仓 |
| 25 | LXEO | Lexeo Therapeutics INC | -0.5% | +5.33% | 加仓 |
| 26 | PTGX | Protagonist Therapeutics INC | -0.6% | -5.25% | 减仓 |
| 27 | IKT | Inhibikase Therapeutics INC | -0.6% | -18.07% | 减仓 |
| 28 | TFX | Teleflex INC | -0.6% | -73.72% | 减仓 |
| 29 | BBIO | Bridgebio Pharma INC | -0.8% | -55.82% | 减仓 |
| 30 | SEPN | Septerna INC | -0.8% | -5.86% | 减仓 |
| 31 | FULC | Fulcrum Therapeutics INC | -1% | -90.10% | 减仓 |
| 32 | ABUS | Arbutus Biopharma CORP | -1.1% | -42.14% | 减仓 |
| 33 | ABVX | Abivax Sa-adr | -3.6% | +9.16% | 加仓 |
| 34 | RNAGBP | Avidity Biosciences INC | — | EXIT | 清仓 |
| 35 | BEAM | Beam Therapeutics INC | — | NEW | 新建仓 |
| 36 | VIR | Vir Biotechnology INC | — | NEW | 新建仓 |
| 37 | DBVT | Dbv Technologies Sa-spon Adr | — | NEW | 新建仓 |
| 38 | RAPT | Rapt Therapeutics INC | — | EXIT | 清仓 |
| 39 | CDTX | Cidara Therapeutics INC | — | EXIT | 清仓 |
| 40 | YCY-UN | AA Mission Acquisition Corp. II | — | EXIT | 清仓 |
| 41 | ✓ | Helix Acquisition CORP Iii | — | NEW | 新建仓 |
| 42 | MLTX | Moonlake Immunotherapeutics | — | NEW | 新建仓 |
| 43 | MPLT | Maplight Therapeutics INC | — | NEW | 新建仓 |
| 44 | DMRA | Damora Therapeutics INC | — | NEW | 新建仓 |
| 45 | PRME | Prime Medicine INC | — | NEW | 新建仓 |
| 46 | KRRO | Korro Bio INC | — | NEW | 新建仓 |
| 47 | INSM | Insmed INC | — | NEW | 新建仓 |
| 48 | BBIO 2.25 02-01-29 | Bridgebio Pharma INC | — | NEW | 新建仓 |
| 49 | ✓ | Bhav Acquisition CORP | — | NEW | 新建仓 |
| 50 | BBIO 1.75 03-01-31 | Bridgebio Pharma INC | — | NEW | 新建仓 |
| 季度 | 申报日期 | 类型 | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-18 | 13F-HR | 在 EDGAR 上查看 |
| 2025-12-31 | 2026-02-18 | 修正案 | 在 EDGAR 上查看 |
| 2025-12-31 | 2026-02-17 | 13F-HR | 在 EDGAR 上查看 |
| 2025-09-30 | 2025-11-14 | 13F-HR | 在 EDGAR 上查看 |
| 2025-06-30 | 2025-08-14 | 13F-HR | 在 EDGAR 上查看 |
| 2025-03-31 | 2025-05-15 | 13F-HR | 在 EDGAR 上查看 |
| 2024-12-31 | 2025-02-13 | 13F-HR | 在 EDGAR 上查看 |
| 2024-09-30 | 2024-11-14 | 13F-HR | 在 EDGAR 上查看 |
| 2024-06-30 | 2024-08-13 | 13F-HR | 在 EDGAR 上查看 |
| 2024-03-31 | 2024-05-15 | 13F-HR | 在 EDGAR 上查看 |
| 2023-12-31 | 2024-02-14 | 13F-HR | 在 EDGAR 上查看 |
资产规模相近的机构
CIK 0001595725
申报总市值
US$17.0亿
100 stks
2026-03-31
资产规模与本机构相差仅 0.1%
CIK 0001396835
申报总市值
US$17.0亿
70 stks
2026-03-31
资产规模与本机构相差仅 0.1%
CIK 0001697953
申报总市值
US$16.9亿
483 stks
2026-03-31
资产规模与本机构相差仅 0.2%
持仓风格相似的机构
CIK 0001839209
申报总市值
US$37.7亿
6 stks
2026-03-31
前五大持仓重叠 2/5 档，同样重仓 Abivax Sa-adr
CIK 0001952142
申报总市值
US$5.2亿
84 stks
2026-03-31
前五大持仓重叠 2/5 档，同样重仓 Abivax Sa-adr
CIK 0002011081
申报总市值
US$11.8亿
51 stks
2026-03-31
前五大持仓重叠 2/5 档，同样重仓 Abivax Sa-adr